NCT07453563 Airway Scope vs GlideScope for Intubation in Obese Patients
| NCT ID | NCT07453563 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of New Mexico |
| Condition | Intratracheal Inbubation |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-07-13 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-07-13 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares the time required to complete intubation in obese patients (Body Mass Index 40 or greater) when using either the GlideScope or Airway Scope video laryngoscope device to help place the endotracheal tube.
Eligibility Criteria
Inclusion Criteria: * Adult (age ≥18 years) * Body Mass Index (BMI) ≥40 * Scheduled for surgery with general anesthesia Exclusion Criteria: * Pregnancy * Congenital facial or airway anomalies * History of major neck surgery or tracheostomy * History of any lung diseases/conditions such as Chronic Obstructive Pulmonary Disease, lung resection, or lung cancer * History of cardiac failure or myocardial infarction * Prisoners
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07453563 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intratracheal Inbubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07453563 currently recruiting?
Yes, NCT07453563 is actively recruiting participants. Contact the research team at YKashiwagi@salud.unm.edu for enrollment information.
Where is the NCT07453563 trial being conducted?
This trial is being conducted at Albuquerque, United States.
Who is sponsoring the NCT07453563 clinical trial?
NCT07453563 is sponsored by University of New Mexico. The trial plans to enroll 70 participants.